The use of CRISPR/Cas9 is having a dramatic impact on virtually every biotechnology field, from crop science to tumor biology.
RHS technology focuses on advanced single cell genomic technologies, targeting the improvement of health and research outcomes.
Learn more about RHS technology
AACC 2018 /// PROVIDER OF INNOVATIVE, SAMPLE TO ANSWER GENOMIC WORKFLOWS
Chicago, IL | July 29 – August 2
See What’s Happening: Twitter | LinkedIn
Join the PerkinElmer Genomics & Proteomics Roadshow as it tours all across Europe. Meet with our experts, test your samples in the mobile lab, and much, much more. See where we’re headed next!
Follow the tour #OmicsRoadShow
Customer Care | Application Support
Microfluidic Device Support
Liquid Handler Support
Library Preparation Kit Support
Integrated Lab Automation Support
Molecular Cytogenetics Support
Single Cell Sequencing Support
– Application Notes
– White Papers
– Scientific Posters
More coming soon…
The use of CRISPR/Cas9 is having a dramatic impact on virtually every biotechnology field, from crop science to tumor biology. The two key features that set this genome modification system apart from other genomic tools are its efficiency and specificity. However, recent articles have raised some doubts about the specificity of CRISPR/Cas9, leading to speculations regarding its future use in sensitive applications such as gene therapy.
Improving the Efficiency of Metagenomic Analysis of Stool Samples: Here PerkinElmer and Illumina® describe a streamlined, automated workflow from DNA extraction to sequence-ready libraries, which results in high quality data for species identification, metagenomic profiling, and de novo genome assembly.